ArticleActa pharmacologica Sinica2022

Design, synthesis and pharmacological characterization of N-(3-ethylbenzo[d]isoxazol-5-yl) sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia.

Mao-Feng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.